Healthcare provider profile · identity verified

Dmitry Levenson, MD

Internal Medicine · WEBSTER, MA · NPI 1588685671

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	902	270
Lisinopril	Lisinopril	417	130
Amlodipine Besylate	Amlodipine Besylate	351	118
Losartan Potassium	Losartan Potassium	306	87
Omeprazole	Omeprazole	289	91
Hydrochlorothiazide	Hydrochlorothiazide	266	85
Levothyroxine Sodium	Levothyroxine Sodium	255	72
Gabapentin	Gabapentin	249	64
Furosemide	Furosemide	236	64
Metoprolol Succinate	Metoprolol Succinate	236	75
Pantoprazole Sodium	Pantoprazole Sodium	221	65
Metoprolol Tartrate	Metoprolol Tartrate	212	63
Rosuvastatin Calcium	Rosuvastatin Calcium	201	63
Simvastatin	Simvastatin	169	56
Eliquis	Apixaban	160	48
Albuterol Sulfate Hfa	Albuterol Sulfate	152	57
Lorazepam	Lorazepam	150	54
Tamsulosin Hcl	Tamsulosin Hcl	142	50
Trazodone Hcl	Trazodone Hcl	139	49
Metformin Hcl Er	Metformin Hcl	136	38
Allopurinol	Allopurinol	130	39
Metformin Hcl	Metformin Hcl	130	42
Sertraline Hcl	Sertraline Hcl	126	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	35
Atenolol	Atenolol	118	37
Zolpidem Tartrate	Zolpidem Tartrate	112	40
Pravastatin Sodium	Pravastatin Sodium	111	31
Potassium Chloride	Potassium Chloride	109	32
Tramadol Hcl	Tramadol Hcl	105	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	92	30
Alprazolam	Alprazolam	91	31
Oxycodone Hcl	Oxycodone Hcl	87	19
Citalopram Hbr	Citalopram Hydrobromide	82	27
Fluticasone Propionate	Fluticasone Propionate	82	27
Clonazepam	Clonazepam	72	19
Escitalopram Oxalate	Escitalopram Oxalate	71	23
Warfarin Sodium	Warfarin Sodium	65	15
Meclizine Hcl	Meclizine Hcl	62	17
Finasteride	Finasteride	60	18
Diclofenac Sodium	Diclofenac Sodium	59	18
Duloxetine Hcl	Duloxetine Hcl	58	16
Clopidogrel	Clopidogrel Bisulfate	57	16
Fluoxetine Hcl	Fluoxetine Hcl	55	17
Glipizide Er	Glipizide	55	16
Famotidine	Famotidine	54	21
Venlafaxine Hcl Er	Venlafaxine Hcl	54	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	11
Mirtazapine	Mirtazapine	49	13
Alendronate Sodium	Alendronate Sodium	48	14
Ropinirole Hcl	Ropinirole Hcl	47	12
Triamcinolone Acetonide	Triamcinolone Acetonide	46	16
Quetiapine Fumarate	Quetiapine Fumarate	45	17
Prednisone	Prednisone	44	31
Carvedilol	Carvedilol	42	12
Glipizide	Glipizide	41	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	27
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Pregabalin	Pregabalin	37	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Chlorthalidone	Chlorthalidone	34	11
Jardiance	Empagliflozin	34	suppressed
Klor-Con M20	Potassium Chloride	34	12
Ezetimibe	Ezetimibe	33	11
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	32	29
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	12
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	18
Ibuprofen	Ibuprofen	28	18
Spironolactone	Spironolactone	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Tradjenta	Linagliptin	28	suppressed
Clobetasol Propionate	Clobetasol Propionate	27	suppressed
Ozempic	Semaglutide	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Lidocaine	Lidocaine	26	suppressed
Baclofen	Baclofen	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	19
Synthroid	Levothyroxine Sodium	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nitroglycerin	Nitroglycerin	22	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Valsartan	Valsartan	21	suppressed
Nystatin	Nystatin	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Celecoxib	Celecoxib	19	suppressed
Fluocinonide	Fluocinonide	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	14
Propranolol Hcl	Propranolol Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Diazepam	Diazepam	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	14	14
Januvia	Sitagliptin Phosphate	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Pentips Pen Needle	Pen Needle, Diabetic	13	suppressed
Primidone	Primidone	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Temazepam	Temazepam	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Torsemide	Torsemide	11	suppressed
Trospium Chloride Er	Trospium Chloride	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error